reggie78: "Can we start to see share price appreciation to reflect analyst valuations anything like recent Evans Partners $4.40 pre results to & $7.70 after positive results?"
reggie78/others: As usual (JIMHO, of course!) the ASX seems NOT to be capable to understand and value biotech/pharma stocks correctly.... But foreign entities will be able to do so for certain. The RISK of a far 'too low' take-over offer is there - but hopefully by then the majority of NEU share-holders will have kind of "woken-up" to the fact that the NEU share-price should be much, much higher than at the current measly level...
Time will tell as usual. All the best to all NEU holders and buyers. Have the necessary patience. The future here (do NOT forget NZ 2591!) looks extremely bright. Once again: JIMHO, of course. Comments welcome as usual.
wasa
Positive Results!, page-161
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.38 |
Change
-0.070(0.48%) |
Mkt cap ! $1.854B | |||
| Open | High | Low | Value | Volume |
| $14.50 | $14.59 | $14.34 | $1.229M | 84.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 439 | $14.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.39 | 178 | 5 |
View Market Depth
| Last trade - 13.39pm 31/01/2025 (20 minute delay) ? |
| NEU (ASX) Chart |